Next Generation Antibody...

INNONext Generation Antibody Platforms

3rd - 4th December, 2018

Taj Vivanta, MG Road, Bengaluru, India

Sachdev SidhuProf. and Principal Investigator,

University of Toronto

Date:

Venue:

Philip TagariVice President Research,

Amgen Inc.

www.innofocus.in

INNO 2018, a two-day Antibody Symposium will be held on Monday, 3rd - Tuesday, 4th December 2018, in Bengaluru, India. The Symposium aims to expand our understanding of scientific advancements in Antibody Conjugates with active participation from the Pharma & Biotech industries and the Academia.

The event is an excellent occasion to interact with industry leaders such as Dara Wright & Peter Silvester of Thermo Fisher Scientific, Philip Tagari of Amgen Inc., Kiran Mazumdar Shaw, and Jonathan Hunt from Syngene International, and many others.

Please register to listen to our distinguished speakers discuss the latest innovations and advancement in cutting-edge technologies. We invite scientists to present their research learnings through a poster presentation. Kindly register at the earliest as only limited slots are available.

Keynote Speakers

Sponsors

Event Speakers

Ralf GuentherAssociate Director,

Protein Engineering and Antibody,Merck KGaA.

Andreas MenradVice President, Global Head,

New Biologics Technologies,Merck KGaA.

Abhishek MathurDirector,

Biologics Externalization, Amgen Inc.

Maloy GhoshChief Scientific Officer,Zumutor Biologics Inc.

Irina RybinaPrincipal Scientist,

Biotherapeutic Discovery,Boehringer Ingelheim

Deepa ShankarDirector – R&D

Thermo Fisher Scientific

Dinakar SalunkeDirector,

International Centre for Genetic Engineering and Biotechnology

Sreesha Srinivasa Vice President,

Translational Sciences,Biocon Research Ltd.

Kevin HarveyDirector – Antibody and

Assay Platforms,Thermo Fisher Scientific

Kas SubramanianVice President,Bioinformatics,

Syngene International Ltd.

Saurabh A JoshiAssociate Research

Director, Discovery BiologySyngene

International Ltd.

Chadwick KingDirector,

Antibody discovery,Amgen Inc.

Day 1: Monday, 3rd December, 2018

8:00-8:45Registration and Refreshment

9:45-10:30Philip Tagari - Keynote speaker

8:45-9:45Welcome and Opening RemarksKiran Mazumdar Shaw, Jonathan Hunt, Philip Tagari, Peter Silvester and Dara Wright

Inducing or breaking tolerance for difficult-to-make antibodies

11:00-11:40Saurabh A Joshi

11:40-12:20

Addressing Antibody Reproducibility – ABfinity and beyond!

Transgenic animals and Yeast Surface Display – a Versatile Combination for Selection and

Engineering of Mono- and Bispecific Antibodies

Addressing New Challenges in Therapeutic Antibody Discovery with Technology Innovation

13:30-14:10

14:10-14:50

Deepa Shankar

15:00-16:00Refreshment and Poster Session

16:40-17:15Panel Discussion: Saurabh Joshi, Ralf Guenther, Maloy Ghosh, Deepa Shankar and Chadwick KingModerator: Sachdev Sidhu

Ralf Guenther

Human antibody library development for therapeutic monoclonal antibody products

16:00-16:40Maloy Ghosh

10:30-11:00

The Past, Present & Future of Antibody-based Therapeutics

Networking, Refreshment Break & Poster set-up

Chadwick King

12:30-13:30Networking Lunch

Day 2: Tuesday, 4th December, 2018

11:50-12:30Abhishek Mathur

13:30-14:10

14:40-15:10

8.30-9:10

14:10-14:40Kas Subramanian

8:00-8:30

12:30-13:30Networking Lunch

10:00-10:30Networking, Refreshment Break & Poster set-up

11:10-11:50

Construct Design, Expression and Purification of High Quality Reagents for Antibody Generation and Screening

Irina Rybina

Impact of Monoclonal IgG Aggregates on In vitro Bioactivity Assessment

10:30-11:10

Advanced Verification: What Do We mean by Antibody Specificity?

Kevin Harvey

New paradigms of antibody specificity at molecular level

Using QSP to optimize bispecific antibody properties for immunotherapeutic efficacy

15:10-16:10Refreshment and Poster Session

16:45-17:15Awards and closure ceremony of the symposium

Dinakar Salunke

Targeting the tumour and the microenvironment with a bi-functional

monoclonal antibody

Sreesha Srinivas

16:10-16:45Panel Discussion: Andreas, Irina, Abhishek,

Dinakar, Kevin, Kas and SreeshaModerator: Jayashree Aiyar

Refreshment

From Systems Biology to Systems BiologicsSachdev Sidhu - Keynote speaker

Therapeutic Antibodies: Current State and Future Trends

9:10-10:00Andreas Menrad

Poster Presentaion

We invite scientists and students to present their scientific poster and share their research findings on Antibody Conjugates.

Poster size – 3ft x 4ft – portrait orientationShortlisting of posters will be made by the Technical CommitteeShortlisted presenters will be notified by emailEach poster session presenter will be provided with a poster board area and mounting pins. The board will indicate the poster number in the upper right or left corner. Presenters are responsible for installing their posters the morning of their presentation and removing them at the end of the session.Poster presenters to stand next to their poster during the session to exhibit and explain their work to the symposium attendeesFor queries please contact: divya.khaitan@syngeneintl.com

Guidelines for Poster Submission

Amgen Inc. focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen Inc. has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.For more details, visit www.amgen.com.

Syngene International Ltd., an innovation-focused global discovery, development and manufacturing organisation offers integrated services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemicals industries across the world. Syngene’s clientele includes market leaders such as Bristol-Myers Squibb, Baxter, Amgen Inc. , GSK, Zoetis, Merck KGaA and Herbalife. Its innovative culture is driven by a strong team of over 3,500 scientists working with clients around the world to improve R&D productivity while reducing development time and cost.For more details, visit www.syngeneintl.com.

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

Sponsors